Clinical Trials Browser

Mouth Neoplasms

Locally Advanced Cervical Adenocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Mycosis Fungoides

Extensive Stage Lung Small Cell Carcinoma

Breast Neoplasms

Urinary Bladder Neoplasms

Breast Neoplasms

Burkitt Lymphoma

Neuroblastoma, Ganglioneuroblastoma

Rectal Neoplasms

Prostatic Neoplasms

Pancreatic Neoplasms

Salivary Gland Neoplasms

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Adenocarcinoma of Lung, Lung Neoplasms

Nasopharyngeal Carcinoma

Urinary Bladder Neoplasms

Carcinoma, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Sinonasal Squamous Cell Carcinoma

Breast Neoplasms

Glioblastoma, Recurrence

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Colorectal Neoplasms

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Biphenotypic, Acute

Prostatic Neoplasms

Multiple Myeloma

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Anus Neoplasms

Clinical Trials

Clinical and Molecular Features of Oral Premalignancy and Oral Cancer

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

DEBRA

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

TAILOR RT

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

NEO-RT

ASCENDE-SBRT

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

GBM AGILE

LAP100

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

Hypofractionation (Radiation) Trial for Multiple Myeloma

Hyperpolarized Imaging in Diagnosing Participants With Glioma

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer